GCM Medical Group, PSC - Hato Rey Site

San Juan, PR 917

0 studies enrolling now · 10 studies all time

What they study most

Atopic Dermatitis, Dermatitis, Atopic, Obesity, Overweight, Overweight or Obesity, Plaque Psoriasis, Psoriasis, Systemic Lupus Erythematosus, Type 2 Diabetes, Type 2 Diabetes Mellitus

Studies at this site

• A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001 — Completed
• A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes — Running, not enrolling
• A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities — Running, not enrolling
• A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin — Completed
• A IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Moderately Active Systemic Lupus Erythematosus — Stopped early
• A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE) — Completed
• A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3) — Stopped early
• A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis — Stopped early
• A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus — Completed
• A Study of LY3454738 in Healthy Participants and Participants With Atopic Dermatitis — Completed